LGALS1 and peripheral arterial disease: Second, we demonstrated independent associations between galectin-1, alpha-1-microglobulin, and galectin-9 and 2-year MACE in the patients with PAD after controlling for the baseline demographic and clinical characteristics, including existing CAD and CVD.